A protocol for a randomized trial evaluating the role of carbon ‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma

ConclusionThe results of the trial may shed insights on the combined therapy with ICIs and CIRT.

Source: Cancer Medicine - January 11, 2024 Category: Cancer & Oncology Authors: Jiyi Hu, Qingting Huang, Weixu Hu, Jing Gao, Jing Yang, Haojiong Zhang, Jiade Jay Lu, Lin Kong Tags: RESEARCH ARTICLE Source Type: research